{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:07:48Z","timestamp":1775279268069,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW112-TDU-B-222-124009"],"award-info":[{"award-number":["MOHW112-TDU-B-222-124009"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bj.2024.100757","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T17:25:44Z","timestamp":1719422744000},"page":"100757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis"],"prefix":"10.1016","volume":"48","author":[{"given":"Kun-Ming","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/ajt.14267","article-title":"Obituary of thomas E. Starzl, MD, PhD","volume":"17","author":"Fung","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00000658-199308000-00005","article-title":"Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients","volume":"218","author":"Bismuth","year":"1993","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib3","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.bj.2024.100757_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2019.11.017","article-title":"Advances in resection and transplantation for hepatocellular carcinoma","volume":"72","author":"Vibert","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bj.2024.100757_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.asjsur.2011.08.005","article-title":"Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome","volume":"34","author":"Chan","year":"2011","journal-title":"Asian J Surg"},{"issue":"11","key":"10.1016\/j.bj.2024.100757_bib8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1634\/theoncologist.12-11-1321","article-title":"Liver transplantation for hepatocellular carcinoma in Asia","volume":"12","author":"de Villa","year":"2007","journal-title":"Oncol"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.21037\/hbsn.2016.08.02","article-title":"Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes","volume":"5","author":"Lin","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib10","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.seminoncol.2012.05.008","article-title":"Developments in liver transplantation for hepatocellular carcinoma","volume":"39","author":"Melloul","year":"2012","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","article-title":"Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series","volume":"25","author":"Sugawara","year":"2007","journal-title":"Dig Dis"},{"issue":"12","key":"10.1016\/j.bj.2024.100757_bib73","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","article-title":"Liver transplantation for hepatocellular carcinoma: hangzhou experiences","volume":"85","author":"Zheng","year":"2008","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bj.2024.100757_bib74","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","article-title":"Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center","volume":"14","author":"Lee","year":"2008","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.bj.2024.100757_bib75","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/hep.22693","article-title":"Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database","volume":"49","author":"Toso","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib76","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00534-009-0162-y","article-title":"Liver transplantation for hepatocellular carcinoma: the Kyoto experience","volume":"17","author":"Takada","year":"2010","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/SLA.0b013e31820508f1","article-title":"Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion","volume":"253","author":"DuBay","year":"2011","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib78","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including alpha-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1600-6143.2007.02138.x","article-title":"A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria","volume":"8","author":"Volk","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2018.12.029","article-title":"Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation","volume":"70","author":"Goldaracena","year":"2019","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.bj.2024.100757_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.3112","article-title":"Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant","volume":"156","author":"Lai","year":"2021","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.bj.2024.100757_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.0007-1323.2001.02034.x","article-title":"Estimation of prognosis after hepatectomy for hepatocellular carcinoma","volume":"89","author":"Lee","year":"2002","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.bj.2024.100757_bib18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1245\/s10434-009-0448-y","article-title":"Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma","volume":"16","author":"Wang","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/lt.21738","article-title":"Improved results of transplantation for hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation","volume":"15","author":"Onaca","year":"2009","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/hep.24231","article-title":"Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation","volume":"53","author":"Bhangui","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1245\/s10434-008-9846-9","article-title":"Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors","volume":"15","author":"Sumie","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1245\/s10434-012-2513-1","article-title":"A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability","volume":"20","author":"Rodriguez-Peralvarez","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4254\/wjh.v6.i2.64","article-title":"Portal vein thrombosis in liver cirrhosis","volume":"6","author":"Kinjo","year":"2014","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0168-8278(00)80259-7","article-title":"Portal vein thrombosis in adults: pathophysiology, pathogenesis and management","volume":"32","author":"Valla","year":"2000","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.bj.2024.100757_bib26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MCG.0b013e3182a8a254","article-title":"Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact","volume":"48","author":"Lee","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1665-2681(19)30797-5","article-title":"Portal vein thrombosis: what is new?","volume":"14","author":"Manzano-Robleda Mdel","year":"2015","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.25345","article-title":"Distinguishing tumor from bland portal vein thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA criteria","volume":"25","author":"Sherman","year":"2019","journal-title":"Liver Transplant"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/lt.22044","article-title":"Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation","volume":"16","author":"Piscaglia","year":"2010","journal-title":"Liver Transplant"},{"issue":"18","key":"10.1016\/j.bj.2024.100757_bib31","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3748\/wjg.15.2245","article-title":"Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients","volume":"15","author":"Sorrentino","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"32","key":"10.1016\/j.bj.2024.100757_bib32","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.3748\/wjg.v21.i32.9457","article-title":"Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma","volume":"21","author":"Tarantino","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.bj.2024.100757_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071571","article-title":"\u00b9\u2078F-FDG PET metabolic parameters and MRI perfusion and diffusion parameters in hepatocellular carcinoma: a preliminary study","volume":"8","author":"Ahn","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00261-014-0170-5","article-title":"The role of 18F-FDG PET\/CT in differentiating malignant from benign portal vein thrombosis","volume":"39","author":"Hu","year":"2014","journal-title":"Abdom Imag"},{"issue":"7","key":"10.1016\/j.bj.2024.100757_bib35","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s00261-019-01997-2","article-title":"Value of (18)F-FDG PET\/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma","volume":"44","author":"Wu","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"9","key":"10.1016\/j.bj.2024.100757_bib36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00534-010-0314-0","article-title":"A new classification for hepatocellular carcinoma with portal vein tumor thrombus","volume":"18","author":"Shi","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"11","key":"10.1016\/j.bj.2024.100757_bib38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1872-034X.2010.00731.x","article-title":"Report of the 18th follow-up survey of primary liver cancer in Japan","volume":"40","author":"Ikai","year":"2010","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/lt.24610","article-title":"Macrovascular invasion is not an absolute contraindication for living donor liver transplantation","volume":"23","author":"Lee","year":"2017","journal-title":"Liver Transplant"},{"issue":"8","key":"10.1016\/j.bj.2024.100757_bib69","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/lt.24782","article-title":"The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation","volume":"23","author":"Choi","year":"2017","journal-title":"Liver Transplant"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11605-016-3302-0","article-title":"Liver transplantation after transarterial chemoembolization and radiotherapy for hepatocellular carcinoma with vascular invasion","volume":"21","author":"Jeong","year":"2017","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.bj.2024.100757_bib71","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/TP.0000000000003162","article-title":"Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging","volume":"104","author":"Soin","year":"2020","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib80","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/tri.13586","article-title":"Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study","volume":"33","author":"Assalino","year":"2020","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.bj.2024.100757_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hbpd.2020.03.009","article-title":"Alpha-fetoprotein and (18)F-FDG standard uptake value predict tumor recurrence after liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis: preliminary experience","volume":"19","author":"Yang","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3349\/ymj.2021.62.1.29","article-title":"Comparison of liver transplantation and liver resection for hepatocellular carcinoma patients with portal vein tumor thrombus Type I and Type II","volume":"62","author":"Lv","year":"2021","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00432-021-03665-9","article-title":"Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion","volume":"148","author":"Bhatti","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejso.2021.08.014","article-title":"Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study","volume":"48","author":"Yu","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.bj.2024.100757_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.971532","article-title":"Clinical analysis of deceased donor liver transplantation in the treatment of hepatocellular carcinoma with segmental portal vein tumor thrombus: a long-term real-world study","volume":"12","author":"Sha","year":"2022","journal-title":"Front Oncol"},{"issue":"17","key":"10.1016\/j.bj.2024.100757_bib85","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.3390\/cancers15174225","article-title":"Long-Term outcomes of liver transplantation in hepatocellular carcinoma with bile duct tumor thrombus: a comparison with portal vein tumor thrombus","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000367737","article-title":"Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein thrombosis: impact of early response to 4 Weeks of treatment","volume":"4","author":"Lin","year":"2015","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000488156","article-title":"Hepatic arterial infusion chemotherapy: a potential therapeutic option for hepatocellular carcinoma with portal vein tumor thrombus","volume":"7","author":"Moriguchi","year":"2018","journal-title":"Liver Cancer"},{"issue":"7","key":"10.1016\/j.bj.2024.100757_bib44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2967\/jnumed.117.199752","article-title":"90Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort","volume":"59","author":"Abouchaleh","year":"2018","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.bj.2024.100757_bib45","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/lt.26257","article-title":"Deceased donor liver transplantation after radioembolization for hepatocellular carcinoma and portal vein tumoral thrombosis: a pilot study","volume":"27","author":"Serenari","year":"2021","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib46","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","author":"Spreafico","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/liv.13191","article-title":"Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area","volume":"37","author":"Im","year":"2017","journal-title":"Liver Int"},{"issue":"36","key":"10.1016\/j.bj.2024.100757_bib48","doi-asserted-by":"crossref","first-page":"24537","DOI":"10.18632\/oncotarget.25224","article-title":"Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bj.2024.100757_bib49","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.2147\/OTT.S113161","article-title":"Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus","volume":"9","author":"Wu","year":"2016","journal-title":"OncoTargets Ther"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2015.11.019","article-title":"Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: an external validation study","volume":"118","author":"Yu","year":"2016","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.bj.2024.100757_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268779","article-title":"Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: a meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.bj.2024.100757_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6017406","article-title":"Efficacy of external beam radiation-based treatment plus locoregional therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis","volume":"2016","author":"Chen","year":"2016","journal-title":"BioMed Res Int"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib53","doi-asserted-by":"crossref","first-page":"966","DOI":"10.21037\/hbsn-23-410","article-title":"Proton beam therapy for downstaging hepatocellular carcinoma with lobar portal vein tumor thrombosis to living donor liver transplantation","volume":"12","author":"Chen","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib54","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/cncr.21237","article-title":"Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"104","author":"Hata","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib55","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5009\/gnl.2013.7.6.696","article-title":"Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis","volume":"7","author":"Jeong","year":"2013","journal-title":"Gut Liver"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10637-017-0468-6","article-title":"The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis","volume":"36","author":"Kuo","year":"2018","journal-title":"Invest N Drugs"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bj.2024.100757_bib58","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2018.11.029","article-title":"Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: the phase III STAH trial","volume":"70","author":"Park","year":"2019","journal-title":"J Hepatol"},{"issue":"10064","key":"10.1016\/j.bj.2024.100757_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"issue":"10126","key":"10.1016\/j.bj.2024.100757_bib60","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bj.2024.100757_bib61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100757_bib62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in patients with advanced and progressing hepatocellular carcinoma","volume":"379","author":"Abou-Alfa","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.bj.2024.100757_bib63","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bj.2024.100757_bib64","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"issue":"6","key":"10.1016\/j.bj.2024.100757_bib65","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s12328-021-01521-4","article-title":"Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy","volume":"14","author":"Dehghan","year":"2021","journal-title":"Clin J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bj.2024.100757_bib66","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/ajt.15617","article-title":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: are checkpoint inhibitors safe for the pretransplant patient?","volume":"20","author":"Nordness","year":"2020","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.bj.2024.100757_bib67","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1097\/TXD.0000000000000814","article-title":"Liver allograft failure after nivolumab treatment-A case report with systematic literature research","volume":"4","author":"Gassmann","year":"2018","journal-title":"Transplant Direct"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941702400060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S231941702400060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T18:28:37Z","timestamp":1749234517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S231941702400060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S231941702400060X"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100757","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100757"}}